The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation of the combination of CT-derived tumor texture and vessel tortuosity on survival outcomes for immunotherapy but not for chemotherapy in metastatic non-small cell lung cancer (mNSCLC): Results from a CheckMate227 (CM227) subset.
 
Pushkar Mutha
No Relationships to Disclose
 
Mohammadhadi Khorrami
No Relationships to Disclose
 
Babajide Sonuga
No Relationships to Disclose
 
Kshitij Aggarwal
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Wiem Safta
Employment - Bristol-Myers Squibb
 
Diederik J. Grootendorst
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
David Paulucci
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Oana Mustatea
Employment - Bristol-Myers Squibb
 
Brook Nepon Sixt
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
David Witt
Employment - Bristol-Myers Squibb
 
Hilmi Al-Shakhshir
No Relationships to Disclose
 
Vidya Sankar Viswanathan
Stock and Other Ownership Interests - Pfizer
 
Jeremy Callahan
No Relationships to Disclose
 
Vamsidhar Velcheti
Honoraria - Galvanize Therapeutics
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology; Merck; Novocure; Picture Health; Regeneron; Taiho Oncology; Takeda
Research Funding - Alkermes (Inst); Altor BioScience (Inst); Atreca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech (Inst); Genoptix (Inst); GlaxoSmithKline (Inst); Heat Biologics (Inst); Leap Therapeutics (Inst); Merck (Inst); NantWorks (Inst); OncoPlex Diagnostics (Inst); RSIP Vision (Inst); Trovagene (Inst)
 
Anant Madabhushi
Employment - Picture Health; Picture Health
Leadership - Inspirata; Picture Health
Stock and Other Ownership Interests - Elucid Bioimaging; Inspirata; Picture Health
Honoraria - AstraZeneca; Inspirata
Consulting or Advisory Role - Aiforia; Caris Life Sciences; Castle Biosciences; Cernostics; Merck; Roche; SimBioSys
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol Myers-Squibb (Inst); Inspirata (Inst); Philips Healthcare (Inst)
Patents, Royalties, Other Intellectual Property - IP Licensed by Elucid Bioimaging (Inst); IP licensed by Inspirata Inc. (Inst); Technologies licensed from Case Western Reserve University to Picture Health